IDSA GUIDELINES Bundle (free trial)

Prosthetic Joint Infection

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/100170

Contents of this Issue

Navigation

Page 9 of 15

Treatment Figure 2. Management of PJI-II Duration of symptoms < 3 weeks OR Joint age < 30 days YES NO ������ Well fixed prosthesis ������ Absence of sinus tract ������ Susceptible to oral antimicrobial agentsa YES Debridement and retention a b NO Removal of prosthesisb Antimicrobial agents that are safe for prolonged use for chronic suppression or treatment of biofilm bacteria (see full text guidelines for details) See Figure 3 and full text guidelines for possible exceptions Figure 3. Management of PJI-III - Removal of Prosthesis The patient has: ������ THAa ������ Good soft tissue ������ Good bone stock ������ Preoperatively identified organisms susceptible to oral agents with high oral bioavailability ������ Available antibioticimpregnated bone cement for fixation ������ No requirment for bone grafting One-stage exchange a b 8 Uncommonly performed in the US Relative indications -- See full text guidelines The patient has: ������ Poor soft tissue, OR ������ Difficult-to-treat micro-organisms, AND ������ No prior two-stage exchange for infection OR prior two-stage exchange and reason for failureb AND ������ Technically feasible delayed reimplantation, AND ������ Anticipated good functional outcome YES NO Two-stage exchange See Figure 4

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Prosthetic Joint Infection